PAVmed-subsidiary Lucid Diagnostics spikes on Veterans Affairs contract
Source: SeekingAlpha
2026-01-21 08:47:16 ET
More on Lucid Diagnostics, PAVmed
- PAVmed Inc. (PAVM) Shareholder/Analyst Call Prepared Remarks Transcript
- Lucid Diagnostics Inc. 2025 Q3 - Results - Earnings Call Presentation
- PAVmed Inc. 2025 Q3 - Results - Earnings Call Presentation
- PAVmed announces 1-for-30 reverse stock split
- Lucid Diagnostics signals imminent Medicare coverage for EsoGuard while strengthening commercial payer engagement
Read the full article on Seeking Alpha
For further details see:
PAVmed-subsidiary Lucid Diagnostics spikes on Veterans Affairs contract
Lucid Diagnostics Inc.
NASDAQ: LUCD
LUCD Trading
-1.76% G/L:
$1.3901 Last:
244,935 Volume:
$1.39 Open:
LUCD Latest News
February 04, 2026 08:01:00 am
PAVmed Closes Preferred Stock and Senior Secured Note Financings, Eliminating All Previously Outstanding Convertible Securities
January 21, 2026 08:00:00 am
Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard®
LUCD Stock Data
$166,596,432
87,428,706
0.61%
29
N/A
Medical Equipment & Supplies
Healthcare
US
New York
